% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@INBOOK{Willuweit:858935,
      author       = {Willuweit, A. and Lohmann, P. and Stegmayr, C.},
      title        = {{CHAPTER} 19. {P}reclinical {A}pplications of {MR}-{PET}},
      address      = {Cambridge},
      publisher    = {Royal Society of Chemistry},
      reportid     = {FZJ-2018-07771},
      series       = {New Developments in NMR},
      pages        = {368 - 378},
      year         = {2018},
      comment      = {Hybrid MR-PET Imaging / Shah, N Jon (Editor)
                      doi:10.1039/9781788013062},
      booktitle     = {Hybrid MR-PET Imaging / Shah, N Jon
                       (Editor) doi:10.1039/9781788013062},
      abstract     = {Combined magnetic resonance-positron emission tomography
                      (MR-PET), acquired either simultaneously in hybrid scanners
                      or sequentially with standalone machines, offers various
                      applications for preclinical studies. For example, in order
                      to develop new diagnostic tools for translation into the
                      clinic, proof-of-concept studies enable the development and
                      implementation of new hardware components and MRI sequences.
                      New PET tracers and contrast agents can also be applied and
                      cross-validated with either modality. Currently, dual-probes
                      are under development, which synergistically combine the
                      advantages of imaging agents from PET and magnetic resonance
                      imaging. MR-PET is also being implemented more frequently to
                      support the monitoring of preclinical treatment studies for
                      the development of new therapeutic agents and strategies.
                      Further applications of combined MR-PET are multi-modal
                      validation studies of new animal models and analysis of
                      brain function and disease mechanisms, which can be
                      monitored longitudinally.},
      cin          = {INM-4 / INM-11 / JARA-BRAIN},
      cid          = {I:(DE-Juel1)INM-4-20090406 / I:(DE-Juel1)INM-11-20170113 /
                      $I:(DE-82)080010_20140620$},
      pnm          = {573 - Neuroimaging (POF3-573)},
      pid          = {G:(DE-HGF)POF3-573},
      typ          = {PUB:(DE-HGF)7},
      doi          = {10.1039/9781788013062-00368},
      url          = {https://juser.fz-juelich.de/record/858935},
}